Capital Advisors Ltd’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-37
Closed – – 1537
2025
Q1
$0 Hold
37
– – ﹤0.01% 1505
2024
Q4
$1K Hold
37
– – ﹤0.01% 1258
2024
Q3
$1K Hold
37
– – ﹤0.01% 1249
2024
Q2
$1K Hold
37
– – ﹤0.01% 1243
2024
Q1
$1K Hold
37
– – ﹤0.01% 1231
2023
Q4
$1K Hold
37
– – ﹤0.01% 1184
2023
Q3
$0 Hold
37
– – ﹤0.01% 1406
2023
Q2
$1K Hold
37
– – ﹤0.01% 1187
2023
Q1
$1K Hold
37
– – ﹤0.01% 1072
2022
Q4
$0 Sell
37
-195
-84% -$1.82K ﹤0.01% 1491
2022
Q3
$2K Hold
232
– – ﹤0.01% 876
2022
Q2
$2K Buy
+232
New +$2.21K ﹤0.01% 680

Other funds holding NEO

Capital Advisors Ltd's NEO Position: Q2 2025 in Review

Capital Advisors Ltd sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 37 shares.

Capital Advisors Ltd first reported a position in NEO in Q2 2022 and held it in 12 quarters. The position peaked at $2K in Q3 2022. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Capital Advisors Ltd reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 37 NeoGenomics shares in Q2 2025.
  • Capital Advisors Ltd first reported a position in NeoGenomics in Q2 2022 and held it in 12 quarters.
  • Capital Advisors Ltd's NeoGenomics position peaked at $2K in Q3 2022.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Capital Advisors Ltd's 13F filing for Q2 2025, filed 24 Jul 2025.